全文获取类型
收费全文 | 1350篇 |
免费 | 123篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 66篇 |
妇产科学 | 27篇 |
基础医学 | 162篇 |
口腔科学 | 23篇 |
临床医学 | 96篇 |
内科学 | 352篇 |
皮肤病学 | 25篇 |
神经病学 | 34篇 |
特种医学 | 49篇 |
外科学 | 302篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 69篇 |
眼科学 | 29篇 |
药学 | 72篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 142篇 |
出版年
2023年 | 8篇 |
2022年 | 16篇 |
2021年 | 57篇 |
2020年 | 27篇 |
2019年 | 48篇 |
2018年 | 53篇 |
2017年 | 44篇 |
2016年 | 30篇 |
2015年 | 57篇 |
2014年 | 70篇 |
2013年 | 64篇 |
2012年 | 89篇 |
2011年 | 112篇 |
2010年 | 59篇 |
2009年 | 44篇 |
2008年 | 61篇 |
2007年 | 65篇 |
2006年 | 51篇 |
2005年 | 61篇 |
2004年 | 46篇 |
2003年 | 37篇 |
2002年 | 43篇 |
2001年 | 36篇 |
2000年 | 28篇 |
1999年 | 25篇 |
1998年 | 6篇 |
1997年 | 8篇 |
1996年 | 8篇 |
1995年 | 8篇 |
1993年 | 5篇 |
1992年 | 19篇 |
1991年 | 22篇 |
1990年 | 15篇 |
1989年 | 10篇 |
1988年 | 13篇 |
1987年 | 14篇 |
1986年 | 10篇 |
1985年 | 10篇 |
1984年 | 5篇 |
1983年 | 15篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1976年 | 8篇 |
1975年 | 3篇 |
1974年 | 9篇 |
1973年 | 6篇 |
1972年 | 6篇 |
1971年 | 5篇 |
1970年 | 10篇 |
1967年 | 3篇 |
排序方式: 共有1477条查询结果,搜索用时 15 毫秒
71.
Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder 总被引:7,自引:0,他引:7
Spencer T Biederman J Wilens T Faraone S Prince J Gerard K Doyle R Parekh A Kagan J Bearman SK 《Archives of general psychiatry》2001,58(8):775-782
BACKGROUND: We report on a controlled trial of a mixed amphetamine salts compound (Adderall, dextroamphetamine sulfate, dextro-, levoamphetamine sulfate, dextroamphetamine aspartate, levoamphetamine aspartate, and dextroamphetamine saccharate) in the treatment of adult attention-deficit/hyperactivity disorder (ADHD). METHODS: This was a 7-week, randomized, double-blind, placebo-controlled, crossover study of Adderall in 27 well-characterized adults satisfying full DSM-IV criteria for ADHD of childhood onset and persistent symptoms into adulthood. Medication was titrated up to 30 mg twice a day. Outcome measures included the ADHD Rating Scale and the Clinical Global Impression Score. Comorbid psychiatric disorders were assessed to test for potential effects on treatment outcome. RESULTS: Treatment with Adderall at an average oral dose of 54 mg (administered in 2 daily doses) was effective and well tolerated. Drug-specific improvement in ADHD symptoms was highly significant overall (42% decrease on the ADHD Rating Scale, P<.001), and sufficiently robust to be detectable in a parallel groups comparison restricted to the first 3 weeks of the protocol (P<.001). The percentage of subjects who improved (reduction in the ADHD rating scale of > or =30%) was significantly higher with Adderall treatment than with a placebo (70% vs 7%; P =.001). CONCLUSIONS: Adderall was effective and well tolerated in the short-term treatment of adults with ADHD. More work is needed to evaluate the long-term effects of Adderall, or other amphetamine compounds, in the treatment of adults with ADHD. 相似文献
72.
73.
Anouk T Dev Teresa L Kauf Amany Zekry Keyur Patel Karen Heller Kevin A Schulman John G McHutchison 《BMC health services research》2008,8(1):208
Background
Although clinical research is integral to the advancement of medical knowledge, physicians face a variety of obstacles to their participation as investigators in clinical trials. We examined factors that influence the participation of gastroenterologists and hepatologists in clinical research. 相似文献74.
75.
R. Rodrigues M.D. R. Merchant M.D. S. Parekh M.R.C.P. 《Indian journal of pediatrics》1983,50(4):457-459
The clinical course and investigations of a three year old child who developed cavernous sinus thrombosis are presented, and the problems in the diagnosis and management highlighted. The peculiar features of this case were the presence of a retrobulbar mass and hemiplegia. 相似文献
76.
77.
Toothaker RD Corey AE Valentine SN Agnew JR Parekh N Moehrke W Thompson GA Powell JH 《Journal of clinical pharmacology》2005,45(7):773-780
The influence of coadministration on digoxin and azimilide pharmacokinetics/pharmacodynamics was assessed in a randomized, 3-way crossover study in 18 healthy men. Serial blood and urine samples were obtained for azimilide and digoxin quantitation. Treatment effects on pharmacokinetics were assessed using analysis of variance. The relationship between azimilide blood concentrations and QT(c) prolongation was characterized by an E(max) model. Effects of coadministration on pharmacodynamics were assessed using a mechanistic-based inhibition model. Azimilide pharmacokinetics was unaffected by digoxin, except for a 36% increase in CL(r) (P = .0325), with no change in CL(o). Digoxin pharmacokinetics was unaffected by azimilide, except for a 21% increase in C(max) (P = .0176) and a 10% increase in AUC(tau) (P = .0121). Digoxin coadministration increased the apparent EC(50) with no effect on E(max), consistent with competitive inhibition (K(i) = 0.899 ng/mL). The pharmacokinetic and pharmacodynamic changes observed upon coadministration were small and are not expected to be clinically important. 相似文献
78.
Urinary type calcium hydrogen phosphate dihydrate (CHPD) or Brushite crystals were grown by the single diffusion gel technique in silica hydro-gels. The gel framework acts as a three dimensional crucible in which the crystal nuclei are delicately held in the position of their formation and nutrients are supplied for their growth. This technique can be utilized as a simplified screening model to study the growth and dissolution of urinary stones in vitro. The action of the putatively litholytic medicinal plants Tribulus terrestris and Bergenia ligulata on the growth of CHPD crystals was studied . The effects of artificial reference urine (ARU) and human urine (HU), along with the plant extracts, are also reported. Attempts were made to understand the role of these inhibitors on urinary crystal formation. HU, ARU, extracts of B. ligulata and T. terrestris exhibit appreciable amounts of inhibition, but B.ligulata and T.terrestris with ARU and HU do not show inhibition at all. 相似文献
79.
Parekh K Meyers BF Patterson GA Guthrie TJ Trulock EP Damiano RJ Moazami N 《The Journal of thoracic and cardiovascular surgery》2005,130(3):859-863
BACKGROUND: The clinical results of lung transplantation and concomitant cardiac surgery are unclear. The effect of cardiopulmonary bypass on the pulmonary allograft is controversial, and the effect of cardiac arrest and cardiac surgery in this setting is unknown. Our aim was to review the operative results and long-term survival in this group of patients. METHODS: A retrospective review of all lung transplantations between 1988 and 2003 was performed. Patients who had concomitant cardiac surgery during lung transplantation were compared with those who underwent lung transplantation alone. The variables analyzed included allograft ischemic times, use of cardiopulmonary bypass, early graft dysfunction, postoperative morbidity, survival, length of mechanical ventilation, length of stay in the intensive care unit, and overall hospital stay. RESULTS: During this period, 35 of 700 lung transplant recipients (15 single and 20 bilateral transplantations) underwent concomitant cardiac surgery. The cardiac procedures were for patent foramen ovale (n = 18), atrial septal defect (n = 9), ventricular septal defect (n = 2), coronary bypass (n = 4), and "other" (n = 2). Allograft ischemic time, use of extracorporeal membrane oxygenation, length of hospital stay, operative mortality, and survival were not significantly different between the 2 groups. Ventilator time and intensive care unit stay were longer in the cardiac surgery group. CONCLUSIONS: Cardiac surgery at the time of lung transplantation can be performed with acceptable morbidity and mortality. The immediate and long-term survival in these patients is similar to that of other lung transplant recipients. Lung transplantation should continue to be offered to patients with normal ventricular function who require concomitant limited cardiac surgery. 相似文献
80.